Table of Contents Table of Contents
Previous Page  64 / 90 Next Page
Information
Show Menu
Previous Page 64 / 90 Next Page
Page Background

62

NCCN Guidelines for Patients

®

:

Thyroid Cancer, Version 1.2017

6

Treatment guide

Review

If you don’t have symptoms, your doctor may

observe or consider surgery. If surgery is not

possible, he or she may offer vandetanib or

cabozantinib for symptoms or disease that is

worsening. If the disease is worsening, refer to the

options listed in

Guide 22

. Your doctor may offer

supportive care to help relieve any symptoms you

are having. This treatment is not to cure disease but

to help control or treat symptoms that may interfere

with your daily life.

Review

†

†

Medullary thyroid cancer starts in the

neuroendocrine parafollicular C cells of the

thyroid.

†

†

The inherited type of medullary thyroid cancers

are called MEN2 and familial medullary thyroid

cancer.

†

†

Primary treatment for medullary thyroid cancer

is usually surgery.

†

†

Planning for primary treatment requires

checking calcitonin and CEA, performing

imaging, other blood tests, and possibly genetic

testing before surgery.

†

†

After primary treatment for medullary thyroid

cancer, the surveillance and maintenance

phase will start.

†

†

For recurrent or metastatic medullary thyroid

cancer, your doctor will consider the extent of

disease.

†

†

Your doctor may offer supportive care to help

relieve any symptoms you are having.